Home > Healthcare > Medical Devices > Diagnostic Devices > High Pressure Contrast Media Injectors Market

High Pressure Contrast Media Injectors Market Trends

Report ID: GMI6087
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

High Pressure Contrast Media Injectors Market Trends

Increasing prevalence rate of several chronic diseases including cancer, cardiovascular and neurological disorders across the globe is major factor accelerating the industry. For instance, as per the International Agency for Research on Cancer (IARC), it is estimated that more than 27.5 million new patients will suffer from cancer worldwide by the year 2040.

Additionally, according to the World Health Organization (WHO) estimates, cancer is the one of the leading causes of death in majority of countries globally. This prediction is primarily based on increase in aging population and rising incidence of risk factors such as smoking, unhealthy lifestyle and among others in various regions of the world. Similarly, according to the World Heart Federation, globally, more than half a billion individuals associated with cardiovascular diseases in 2021.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

High pressure contrast media injectors industry was worth USD 176.4 million in 2022 and is estimated to generate USD 551.1 million by 2032, driven by the high incidence rate of numerous diseases along with that the rising requirement for diagnostic imaging procedures.

The consumables segment is set to grow at 11.9% CAGR by 2032 attributed to the rising prevalence of chronic diseases and the growing need for accurate diagnosis and treatment monitoring.

U.S. industry size reached USD 62.9 million in 2022 and is estimated to record considerable growth from 2023-2032 owing to the ongoing advancements in imaging technologies and the growing shift towards minimally invasive procedures.

Bracco Group, Medtron AG, Guerbet Group, Bayer HealthCare LLC, NemotoKyorindo Co., Ltd., ulrich GmbH & Co. KG, GE Healthcare, Apollo RT Co. Ltd., Sino Medical-Device Technology Co., and VIVID IMAGING are some of the major enterprises in the industry.